By Debdeep Gupta | 11 Jul, 2024
Zydus Life hits 52-week high on USFDA nod for Sacubitril and Valsartan
Shares of Zydus Lifesciences touched a 52-week high of Rs 1,203.20 in the early trade on July 11, riding on the final approval from the United States Food and Drug Administration (USFDA) to market a key drug used to treat chronic heart failure.At 09:21 am, Zydus Lifesciences was quoting at Rs 1,178.95, down Rs 1.45, or 0.12 percent, on the BSE.Sacubitril and Valsartan Tablets (24 mg/26 mg, 49 mg/5...
Live Comments
Sunil 2022-08-10 20:04:34
with only 36
Login & Reply Like(0) Dislike(0) Repost SpamPalkin 2022-08-08 16:45:28
CUB already released and available in BSE/NSE website. experts to review and advise
Login & Reply Like(0) Dislike(0) Repost SpamBrijesh01 2022-07-25 21:08:27
CITY UNION BANK 161 SL 159 TARGET 165
Login & Reply Like(0) Dislike(0) Repost SpamLive_Love_Laugh 2022-07-08 10:57:20
What We told happen now this may move 160 levels in this series Sit Tight and add on dips
Login & Reply Like(0) Dislike(0) Repost SpamSaini_Sahab 2022-07-07 19:00:00
this year psu banks will show nice results.so hold it.
Login & Reply Like(0) Dislike(0) Repost SpamINVESTINGPOWER 2022-07-07 09:27:07
City Union Bank: The private lender said it will raise Rs 500 crore from qualified institutional players. The board of directors at a meeting approved raising of further capital through the QIP route to the tune of Rs 500 crore.
Login & Reply Like(0) Dislike(0) Repost SpamArvind01 2022-06-27 13:54:46
Welspun Corp shines on bagging another order for pipeline project in Australia
Login & Reply Like(0) Dislike(0) Repost SpamA1FUTURE_TP1 2022-03-15 14:54:35
An investment operation is one which, upon thorough analysis promises safety of principal and an adequate return. Operations not meeting these requirements are speculative for more info bnfs.at/891m
Login & Reply Like(0) Dislike(0) Repost Spam